Coronavirus live updates: Maharashtra reports 31,855 new Covid cases in highest single-day spike

AstraZeneca will share primary analysis of its COVID-19 vaccine with the most up-to-date data, with an independent panel looking into its U.S. trial, the drugmaker said on Tuesday, following doubts expressed by a U.S health body over the trial data. The drugmaker said data presented on Monday was based on analysis with a cut-off date of Feb. 17, adding that it had reviewed the preliminary assessment of the primary analysis and found it to be consistent with the interim report.

The research, published in the journal Nature Medicine, summarised what experts from a wide range of fields, including neurology, cardiology, and nephrology have seen in their own long-haul Covid-19 patients, and also in existing literature. According to the review authors, chest pain has been reported in up to 20 per cent of Covid-19 survivors two months after recovery from the infection.